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E-mail address: takehito@is.icc.u-tokai.ac.jp (T. SatWe previously reported that IjBL prevents experimental autoimmune arthritis. The molecular
mechanism, however, still remains unclear. In contrast to four splicing-isoforms of IjBL in human,
two isoforms were identiﬁed in mouse. The major isoform IjBL-a(S) suppressed LPS-induced NF-jB
activation and transcription of TNFa and IL-6, but not IL-1b. The suppressive activity required the
nuclear localization signal and the ankyrin repeat domain of IjBL. IjBL did not affect the nuclear
translocation of the NF-jB dimer. These ﬁndings point to IjBL as being a novel member of the
nuclear IjB family, which functions in the nucleus and controls various inﬂammatory responses
including autoimmune arthritis.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Nuclear factor jB (NF-jB) plays central roles in inﬂammatory
responses and is composed of homo- or hetero-dimer of Rel family
proteins, RelA (p65), c-Rel, RelB, p50 and p52 [1]. Inhibitor of jB
(IjB) family members, such as IjBa, IjBb and IjBe, sequester
NF-jB dimer in the cytoplasm as an inactive complex. Upon stim-
ulation, IjB proteins are rapidly degraded by proteasome, allowing
NF-jB dimer to translocate into the nucleus, where it activates the
transcription of target genes [2]. In contrast to those ‘‘classical’’ IjB
proteins, Bcl-3, IjBf, IjBNS and IjBg have been identiﬁed as
nuclear resident IjB proteins that either positively or negatively
regulate NF-jB activity [3,4]. These proteins directly modulate
the transcription of a set of NF-jB-controlled cytokine genes
through the binding to p50 and/or p52 subunit of NF-jB.
We previously reported that SNPs within the NFKBIL1 gene
locus, which encodes IjBL protein, are strongly associated with
rheumatoid arthritis [5]. Furthermore, several autoimmune-disor-
ders such as systemic lupus erythematosus, Sjogren’s syndrome
and Takayasu’s arteritis were also reported to be associated with
the polymorphism of the gene locus [6–8]. Since IjBL containschemical Societies. Published by E
o).the region that has signiﬁcant homology to the ankyrin repeat of
the IjB family, it has been assumed that IjBL modulates NF-jB
activity. However, the precise role of IjBL still remains elusive
[9,10]. Recently, we demonstrated that the forced expression of
human IjBL in mice suppressed the development of experimen-
tally induced arthritis [11]. In the human IjBL-Tg mice, dendritic
cell functions, including support for T cell activation and produc-
tion of inﬂammatory cytokines, were impaired.
In this study, we show that IjBL inhibits NF-jB activity and
inﬂammatory cytokine expression and that this activity requires
its nuclear localization signal (NLS) sequence and ankyrin repeat
domain (ANK), suggesting that IjBL is a novel nuclear IjB family
member that is involved in the control of inﬂammatory responses.2. Materials and methods
2.1. Reagents and cell culture
Lipopolysaccharide (LPS; sc-3535) and antibodies speciﬁc for
IjBa (C-21), RelA (A), IjBL (H-225), Sp1 (PEP2) and b-actin
(C-11) were purchased from Santa Cruz Biotechnology (Santa Cruz,
CA). Anti-p50 (ab7971) and a/b-tubulin (2148) were obtained from
Abcam (Cambridge, UK) and Cell Signaling Technology (Danvers,
MA), respectively. RAW264.7 cells (kindly provided by Dr. N.lsevier B.V. All rights reserved.
Fig. 1. Two IjBL isoforms exist in mouse cells. (A) Schematic representation of IjBL isoforms. Abbreviations: PEST, Proline, Glutamic acid, Serine and Threonine rich
sequence; NLS, Nuclear Localization Signal; ANK, Ankyrin repeat domain; AVS, Alternative Slicing Variant domain; LZ, Leucine Zipper. (B) Human and mouse IjBL loci were
aligned by Mulan program (http://mulan.dcode.org/). Gray histograms show conserved regions more than 70% identical between human and mouse. White, black and gray
boxes represent UTR, ORF and ASV regions, respectively. P1–P5 depict the sites of designed primers. (C) RT-PCR analysis was performed to detect b isoform of IjBL using
cDNAs from indicated tissues or cells (top). P4 and P5 primers were used to amplify IjBL gene fragments. IjBL-encoding plasmids were used as positive controls. Genomic
DNA sequences around exon3 and 4 of IjBL gene among four species are shown (bottom). Solid and dotted rectangles mean splice donor and splice acceptor site, respectively.
Asterisks represent conserved nucleotides beyond species. (D) Transcripts of shorter and longer isoforms were ampliﬁed by PCR (left). P1/P3 and P2/P3 primers were used for
ampliﬁcation of (S) and (L) isoforms, respectively. Genomic DNA sequence boundary of exon1b and intron are shown, and solid rectangle indicates splice donor site (right).
Fig. 2. IjBL-a(S) protein is predominantly expressed in RAW264.7 cells. (A) Whole
cell extracts prepared from indicated cells were subjected to western blotting. The
membrane was probed with anti-IjBL antibody. RAW264.7 cells carrying exon1a-
and 1b-containing IjBL cDNAs were used as positive controls. Both bands
corresponding to a(L) and a(S) were diminished in IjBL-knockdown RAW264.7
cells (data not shown). (B) RAW264.7 cells were stimulated with or without 100
ng/ml LPS as indicated periods and subjected to western blotting analysis.
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tained in DMEM medium supplemented with 10% FBS, 2 mM
L-glutamine, 50 lM 2-ME, 100 U/ml penicillin, and 100 lg/ml
streptomycin.
2.2. Vectors and cell lines
Construction of vectors and establishment of stable cell lines
were essentially described in Supplementary data.
2.3. Polymerase chain reaction (PCR)
Quantitative real-time PCR was performed as described previ-
ously [11]. Data were analyzed by DDCt method. IjBL transcripts
were ampliﬁed by PCR using Gold Taq (Applied Biosystems; Carls-
bad, CA). Oligonucleotide sequences are provided in Supplemen-
tary data.
2.4. Reporter assay
RAW264.7 cells were transfected with pcDNA3 plasmid
expressing IjBL-a(S) and its mutants along with pNF-jB-Luc and
phRL-TK plasmid (both of which were kindly provided by Dr. S.
Matsuda, Kansai Medical Univ.) using Lipofectamine with Plus
Reagent (Invitrogen; Carlsbad, CA). The cells were cultured for
2 days, during the last 18 h of which they were stimulated with
100 ng/ml LPS. Luciferase activity was measured by dual-luciferase
reporter system (Promega; Madison, WI). Transfection efﬁciency
was normalized by Renilla luciferase activity.
2.5. Western blotting
Cells were lysed into buffer containing 20 mM Tris–HCl, pH7.4,
150 mM NaCl, 1% Triton-X 100, 0.5% sodium deoxycholate, 1 mMNa3VO4, 0.5 mM PMSF 1 mM DTT and Complete Protease Inhibitor
Cocktail (Roche; Mannheim, Germany) and incubated on ice for
20 min. Cell debris was removed by centrifugation and superna-
tants were used as whole cell extract. For preparation of cytoplas-
mic and nuclear extracts, cells were lysed into TB buffer (10 mM
HEPES, pH7.9, 10 mM KCl, 1 mM MgCl2, 20% glycerol and 0.1% Tri-
ton X-100 and supplemented with Complete Protease Inhibitor
Cocktail and 0.5 mM PMSF) and incubated on ice for 20 min. Nuclei
were spun down and supernatants were used as cytoplasmic
Fig. 3. IjBL suppresses NF-jB activity in an NLS- and ANK-dependent manner. (A) RAW264.7 cells were transfected with IjBL or its mutants along with NF-jB reporter and
internal control reporter plasmids and stimulated with (closed bar) or without (open bar) 100 ng/ml LPS for 18 h. Luciferase activity was analyzed and normalized with Renilla
luciferase activity. Cell lysates were subjected to western blot analysis and probed with indicated antibodies. Data are representative of at least three independent
experiments and shown as averages ± S.D. ⁄P < 0.05. (B) RAW264.7 cells stably expressing IjBL-a(S) or empty vector control were stimulated with 100 ng/ml LPS for 3 h.
TNFa, IL-6 and IL-1b expressions were analyzed by quantitative real-time PCR. Data shown are representative of three independent experiments. ⁄P < 0.05. (C) HEK293T cells
were transfected with IjBL-a(S) and DNLS and DANK mutants. Cytoplasmic and nuclear extracts were prepared and subjected to immunoblot analysis. The membrane was
probed with indicated antibodies.
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containing 400 mM NaCl. The extracts were separated by SDS–
PAGE and transferred to PVDF membranes. The membranes were
incubated with speciﬁc antibodies, followed by HRP-conjugated
anti-rabbit IgG (NA9340: GE Healthcare; Little Chalfont, UK).
Bound antibodies were visualized by ImmobilonWestern Chemilu-
minescent HRP Substrate (Millipore; Billerica, MA).
2.6. Statistics
Data were analyzed by Student’s t test. Values of P < 0.05 were
considered statistically signiﬁcant.
3. Results
3.1. Identiﬁcation of two IjBL-a isoforms in mouse cells
Previously, it was reported that human IjBL (NFKBIL1) has some
different isoforms produced by alternative splicing and differential
usage of the ﬁrst exon [13]. The b form of IjBL is generated by
alternative splicing at the 30 end of the third exon and lacks the
ASV domain, the function of which is undeﬁned (Fig. 1A). Shorter
(S) isoform utilizes exon1b as the ﬁrst exon, resulting in the
truncation of N-terminus PEST sequence (Fig. 1A and B). As a result,
human IjBL gene encodes four different isoforms: full length,
DPEST, DASV and DPEST-DASV, here termed IjBL-a(L), a(S), b(L)
and b(S), respectively (Fig. 1A). We examined whether the IjBL iso-
forms also exist in mouse cells. Reverse-transcribed PCR (RT-PCR)analysis was performed to identify the b isoform of IjBL using
speciﬁc primers (Fig. 1B, P4 and P5), which were designed to span
the ASV region. IjBL-b isoformwas not detected in any of themouse
tissues tested (Fig. 1C, top left), although it was detected in human
PBMC (Fig. 1C, top right, lower band) as described elsewhere [9].
Comparison of genomic DNA sequence among the four species re-
vealed that the alternative splice donor site (GT dinucleotides) was
only seen in primates; the sitewas substituted toGCorGA inmouse,
rat, cowand soon (Fig. 1C, anddata not shown). These data indicated
that IjBL-b isoform is absent in mouse cells.
Next, we surveyed the PEST sequence-truncated ‘‘S’’ isoform of
IjBL in mouse cells. Since the nucleotide sequence of exons in the
IjBL gene locus is well conserved beyond species (Fig. 1B, and data
not shown), putative exon1b of mouse IjBL was assigned to the
670 to 544 bp upstream of its exon1a. RT-PCR analysis revealed
that exon1b-containing transcript was expressed in mouse
macrophage cell line RAW264.7 cells (Fig. 1D left, P1 + P3) and
the splicing donor site was identiﬁed by DNA sequence analysis
(Fig. 1D, right). There were no in-frame ATG methionine codons
within this alternative exon1b (data not shown). Thus, it is as-
sumed that exon1b-containing transcript is translated from the
second ATG codon residing in exon2 and encoding N-terminally
truncated isoform lacking the PEST sequence, while full-length
protein is translated from the ﬁrst ATG codon within exon1a
(Fig. 1B).
To conﬁrm the expression of IjBL isoform proteins, exon1a- and
exon1b-containing cDNAs were transduced into RAW264.7 cells.
Notably, exon1a-containing cDNA produced two differently-sized
Fig. 4. NF-jB activation in the cytoplasm was not affected by IjBL. Control vector-
and IjBL-a(S)-expressing RAW264.7 cells were stimulated with 100 ng/ml LPS for
indicated periods. Whole cell extracts (A) and nuclear extracts (B) were resolved by
SDS–PAGE and immunoblotted with indicated antibodies. Asterisk indicates non-
speciﬁc band.
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form (Fig. 2A). It is suggested that both the 1st and 2nd ATGs are
used as the start codon when exon1a-containing transcript is
translated (Fig. 1B), resulting in the synthesis of a(S) isoform, as
well as a(L) isoform. Endogenous IjBL proteins were also detected
in RAW264.7 cells and slightly increased after exposure to LPS
(Fig. 2A and B). IjBL-a(S) isoform was predominantly expressed
in both LPS-stimulated and unstimulated RAW264.7 cell (Fig. 2),
although transcripts of IjBL-a(L) were over three times greater
than those of a(S) (data not shown). Since the PEST sequence is
known to play a role as a target for proteolysis (Ref. [12]), it is
assumed that the PEST sequence-truncated ‘‘S’’ isoform is more
stable and predominantly exists in the cells.
3.2. IjBL inhibits NF-jB activity and inﬂammatory cytokine
expression
IjBL contains ANK, which exhibits high homology to ANK of IjB
proteins, raising the possibility that IjBL modulates NF-jB activity.
Upon LPS stimulation of RAW264.7 cells, IjBL-a(S)-transduced
cells signiﬁcantly suppressed NF-jB-driven luciferase activity
compared with empty vector control-transduced cells (Fig. 3A).
This result suggested that IjBL functions as an inhibitor of NF-jB.
It is well known that the expression of inﬂammatory cytokines is
largely dependent on NF-jB activity [2]. Consistent with the result
of the luciferase assay (Fig. 3A), TNFa and IL-6 transcriptions, but
not IL-1b transcription, were suppressed by the forced expression
of IjBL-a(S) (Fig. 3B). It is suggested that IjBL inhibits part, if
not all, of NF-jB-driven gene transcription.
3.3. Nuclear localization signal (NLS) sequence and ankyrin repeat
domain (ANK) are required for IjBL activity
In addition to ANK, IjBL-a(S) contains NLS, ASV and LZ regions
(Fig. 1A). Then, we examined the contribution of these regions tothe IjBL activity. Truncation of NLS (DNLS) and ANK (DANK)
within IjBL-a(S) failed to inhibit NF-jB-driven and IL-6 pro-
moter-driven luciferase activity (Fig. 3A, and data not shown),
while comparable activity was observed in ASV(DASV; relative to
b(S) isoform in human)- or LZ (DLZ)-lacking mutants (Fig. 3A). IjBL
is localized both in the cytoplasm and in the nucleus [13]. The NLS
region is required for nuclear localization, since DNLS is detected
only in the cytoplasm, but not in the nucleus (Fig. 3C). In contrast,
truncation of ANK domain within IjBL did not alter its subcellular
localization (Fig. 3C). Thus, ANK domain is required for the activity
irrespective of its localization. Collectively, it seems clear that IjBL
is a novel member of the nuclear IjB family.
3.4. Nuclear translocation of NF-jB dimer occurs normally even in the
forced expression of IjBL
In resting cells, NF-jB dimer forms an inactive complex with
conventional IjBs such as IjBa. Following activation via TLR,
cytoplasmic IjB proteins are rapidly degraded, allowing NF-jB
dimer to translocate into the nucleus [2]. We examined whether
NF-jB activation cascade in the cytoplasm is inﬂuenced by IjBL.
In both control and IjBL-expressing RAW cells, IjBa was com-
pletely degraded within 30 min and re-synthesized at 60 min
after LPS stimulation (Fig. 4A). Consistent with the kinetics of
IjBa degradation, comparable amounts of NF-jB dimer (com-
posed of RelA and p50) were observed in the nucleus in empty
control and IjBL-expressing RAW cells (Fig. 4B). Cytoplasmic
RelA and p50 levels did not change throughout the periods tested
(data not shown). Therefore, IjBL does not affect the nuclear
translocation of NF-jB. Taken together, these results highlight
the fact that IjBL is a novel member of nuclear IjBs, and that
it negatively regulates transcription of some genes controlled
by NF-jB in the nucleus.4. Discussion
In this study, we showed that IjBL, predominantly a(S) isoform,
inhibited NF-jB activity. Similar to nuclear IjB protein family
IjBf and Bcl-3 (Refs. [14] and [15]), IjBL reduced NF-jB activity
in an NLS and ANK regions-dependent manner without affecting
the nuclear translocation of RelA and p50. These ﬁndings support
the notion that IjBL is a novel member of the nuclear IjB
protein family.
It was reported that IjBNS and Bcl-3 inhibit the transcription of
IL-6 and TNFa, respectively [15,16]. Unlike ‘‘classical’’ IjB proteins,
IjBNS and Bcl-3 exert their roles in the nucleus to stabilize DNA-
bound p50 homo-dimer, which is known to be a transcriptional
inactive complex, resulting in the prevention of RelA-containing
active dimer recruitment to the promoter of inﬂammatory cyto-
kine genes [15,16]. In our preliminary experiment using chromatin
immuno-precipitation technique, the forced expression of IjBL re-
duced the recruitment of RelA on the IL-6 and TNFa promoters
(unpublished data), assuming that IjBL regulates cytokine gene
expression by controlling the binding of active NF-jB complex to
DNA.
It is suggested that IjBNS and Bcl-3 bind to p50 through the
ANK region [17]. Although ANK region of IjBL is required for its
activity, we failed to detect the binding of IjBL to p50 and p52
(data not shown). Since the amino acid sequence of IjBL ANK re-
gion slightly differed from that of Bcl-3 and IjBNS (Ref. [18]), it
is plausible that IjBL binds to some other NF-jB subunit. It seems
intriguing to hypothesize that IjBL binds to RelB and support its
inhibitory function, since RelB is reported to play an inhibitory role
in cytokine gene transcription [19,20]. Further investigations are
needed to clarify the underlying mechanisms for IjBL-mediated
T. Chiba et al. / FEBS Letters 585 (2011) 3577–3581 3581inhibition of NF-jB-dependent gene expression. Transcriptional
regulation of inﬂammatory mediators by IjBL may provide new
insights into how inﬂammatory disorders develop.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.febslet.2011.10.024.
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